Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PBPrestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH)

New York Stock Exchange · Currency in USD
$47.80 ▼ -1.66 (-3.36%)
At close: Oct 23, 4:00 PM ET. Market closed.
$47.80 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:22 PM ET

Summary

Previous Close
$49.46
Open
$49.02
Day's Range
$47.70 – $49.09
52 Week Range
$42.62 – $71.07
Volume
529,440
Avg. Volume
583,004
Market Cap
$2.26B
Beta (5Y Monthly)
0.34
PE Ratio (TTM)
13.31
EPS (TTM)
$3.62
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Sep 27, 2018
1y Target Est
$81.67

Profile: Prestige Consumer Healthcare Inc.

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Full-time employees
890
CEO
Ronald Lombardi

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine).

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $1.07 · Revenue est. $329.15M
DateEst.Actual
Aug 6, 2026$0.89$0.98Beat
May 13, 2026$1.39$1.23Miss
Feb 5, 2026$1.16$1.14Miss
Nov 6, 2025$0.97$1.07Beat
Aug 7, 2025$1.01$0.95Miss
May 8, 2025$1.30$1.32Beat

Analyst view

Consensus price target
$81.67 ▲ +70.9%
Range $66.00 – $93.00
Rating: Buy
Buy 65% · Hold 24% · Sell 12%

Get free alerts on PBH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.